Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Return on Equity (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Return on Equity for 15 consecutive years, with 0.41% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 42.0% to 0.41% in Q4 2025 year-over-year; TTM through Nov 2025 was 0.41%, a 42.0% increase, with the full-year FY2025 number at 0.44%, up 44.0% from a year prior.
  • Return on Equity was 0.41% for Q4 2025 at Cryo Cell International, up from 0.05% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 3.33% in Q2 2021 to a low of 5.73% in Q3 2023.
  • A 5-year average of 0.01% and a median of 0.4% in 2022 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: tumbled -701bps in 2023, then surged 717bps in 2024.
  • Cryo Cell International's Return on Equity stood at 0.46% in 2021, then tumbled by -406bps to 1.42% in 2022, then surged by 294bps to 2.75% in 2023, then plummeted by -100bps to 0.01% in 2024, then soared by 5520bps to 0.41% in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Return on Equity are 0.41% (Q4 2025), 0.05% (Q3 2025), and 0.03% (Q2 2025).